S. Shimamura

Interferon-inducible Mx1 protein is highly expressed in renal tissues from treatment-naïve lupus nephritis, but not in those under immunosuppressive treatment

S. Nishio, Y. Fukasawa, S. Yasuda, 2018, Modern rheumatology.

Clinical significance of plasma presepsin levels in patients with systemic lupus erythematosus

S. Yasuda, T. Atsumi, T. Bohgaki, 2018, Modern rheumatology.

Post-steroid neuropsychiatric manifestations are significantly more frequent in SLE compared with other systemic autoimmune diseases and predict better prognosis compared with de novo neuropsychiatric SLE.

S. Yasuda, T. Atsumi, S. Nakagawa, 2016, Autoimmunity reviews.

Surveillance for the use of mycophenolate mofetil for adult patients with lupus nephritis in Japan

Y. Takasaki, K. Hiromura, N. Tamura, 2015, Modern rheumatology.

A national survey on current use of mycophenolate mofetil for childhood-onset systemic lupus erythematosus in Japan

Y. Takasaki, K. Hiromura, N. Tamura, 2015, Modern rheumatology.

Prognosis and progress in immunotherapies for organ involvements in systemic autoimmune diseases.

T. Kurita, S. Yasuda, T. Atsumi, 2016, Nihon Rinsho Men'eki Gakkai kaishi = Japanese journal of clinical immunology.

MicroRNA-9 ameliorates destructive arthritis through down-regulation of NF-κB1-RANKL pathway in fibroblast-like synoviocytes.

N. Iwasaki, S. Yasuda, T. Atsumi, 2020, Clinical immunology.

Ectopic RASGRP2 (CalDAG-GEFI) expression in rheumatoid synovium contributes to the development of destructive arthritis

N. Iwasaki, S. Yasuda, T. Atsumi, 2018, Annals of the rheumatic diseases.

[Rheumatology: Progress in Diagnosis and Treatments. Topics: IV. Collagen Diseases Except for Rheumatoid Arthritis and Hot Topics; 2. Antiphospholipid syndrome].

T. Horita, S. Shimamura, 2014, Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine.